329 related articles for article (PubMed ID: 26308486)
1. Notch signaling deregulation in multiple myeloma: A rational molecular target.
Colombo M; Galletti S; Garavelli S; Platonova N; Paoli A; Basile A; Taiana E; Neri A; Chiaramonte R
Oncotarget; 2015 Sep; 6(29):26826-40. PubMed ID: 26308486
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
3. Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1.
Mirandola L; Apicella L; Colombo M; Yu Y; Berta DG; Platonova N; Lazzari E; Lancellotti M; Bulfamante G; Cobos E; Chiriva-Internati M; Chiaramonte R
Leukemia; 2013 Jul; 27(7):1558-66. PubMed ID: 23354012
[TBL] [Abstract][Full Text] [Related]
4. Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?
Nwabo Kamdje AH; Krampera M
Blood; 2011 Dec; 118(25):6506-14. PubMed ID: 21979940
[TBL] [Abstract][Full Text] [Related]
5. Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes.
Colombo M; Mirandola L; Platonova N; Apicella L; Basile A; Figueroa AJ; Cobos E; Chiriva-Internati M; Chiaramonte R
Leukemia; 2013 Apr; 27(5):1009-18. PubMed ID: 23307030
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance.
Colombo M; Garavelli S; Mazzola M; Platonova N; Giannandrea D; Colella R; Apicella L; Lancellotti M; Lesma E; Ancona S; Palano MT; Barbieri M; Taiana E; Lazzari E; Basile A; Turrini M; Pistocchi A; Neri A; Chiaramonte R
Haematologica; 2020 Jul; 105(7):1925-1936. PubMed ID: 31582544
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.
Nefedova Y; Cheng P; Alsina M; Dalton WS; Gabrilovich DI
Blood; 2004 May; 103(9):3503-10. PubMed ID: 14670925
[TBL] [Abstract][Full Text] [Related]
8. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.
Takeuchi T; Adachi Y; Ohtsuki Y
Am J Pathol; 2005 Jun; 166(6):1817-26. PubMed ID: 15920166
[TBL] [Abstract][Full Text] [Related]
9. [Notch signaling pathway and multiple myeloma].
Gan ZH; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1380-3. PubMed ID: 19840488
[TBL] [Abstract][Full Text] [Related]
10. Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.
Sabol HM; Ferrari AJ; Adhikari M; Amorim T; McAndrews K; Anderson J; Vigolo M; Lehal R; Cregor M; Khan S; Cuevas PL; Helms JA; Kurihara N; Srinivasan V; Ebetino FH; Boeckman RK; Roodman GD; Bellido T; Delgado-Calle J
Cancer Res; 2021 Oct; 81(19):5102-5114. PubMed ID: 34348968
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
[TBL] [Abstract][Full Text] [Related]
13. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Saltarella I; Frassanito MA; Lamanuzzi A; Brevi A; Leone P; Desantis V; Di Marzo L; Bellone M; Derudas D; Ribatti D; Chiaramonte R; Palano MT; Neri A; Mariggiò MA; Fumarulo R; Dammacco F; Racanelli V; Vacca A; Ria R
Neoplasia; 2019 Jan; 21(1):93-105. PubMed ID: 30529074
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
[TBL] [Abstract][Full Text] [Related]
15. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
Jundt F; Pröbsting KS; Anagnostopoulos I; Muehlinghaus G; Chatterjee M; Mathas S; Bargou RC; Manz R; Stein H; Dörken B
Blood; 2004 May; 103(9):3511-5. PubMed ID: 14726396
[TBL] [Abstract][Full Text] [Related]
16. Osteohematology: To be or Notch to be.
Rothzerg E; Erber WN; Gibbons CLMH; Wood D; Xu J
J Cell Physiol; 2023 Jul; 238(7):1478-1491. PubMed ID: 37269472
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of pumpkin protein on expression of Notch signal in RPMI8226 myeloma cells].
Liu TB; Yang P; Xie JM; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1012-5. PubMed ID: 25130819
[TBL] [Abstract][Full Text] [Related]
18. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
[TBL] [Abstract][Full Text] [Related]
20. The mechanism study of miR-125b in occurrence and progression of multiple myeloma.
Gao D; Xiao Z; Li HP; Han DH; Zhang YP
Cancer Med; 2018 Jan; 7(1):134-145. PubMed ID: 29214735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
